Suppr超能文献

叶片提取物中酚类化合物的微胶囊化及生物可及性

Microencapsulation and Bioaccessibility of Phenolic Compounds of Leaf Extracts.

作者信息

Ștefănescu Bianca Eugenia, Nemes Silvia-Amalia, Teleky Bernadette-Emőke, Călinoiu Lavinia Florina, Mitrea Laura, Martău Gheorghe Adrian, Szabo Katalin, Mihai Mihaela, Vodnar Dan Cristian, Crișan Gianina

机构信息

Department of Pharmaceutical Botany, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.

Life Science Institute, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 400372 Cluj-Napoca, Romania.

出版信息

Antioxidants (Basel). 2022 Mar 30;11(4):674. doi: 10.3390/antiox11040674.

Abstract

In recent years, spp. (bilberry-VMT, lingonberry-VVIT, and blueberry-VCS) have sparked particular interest for their prospective health benefits. The latest investigations have place them as important alternative sources of nutraceuticals as their leaves are the main by-products of berry harvesting. The present study is aimed at investigating the bioaccessibility of phenolic compounds from leaves of the species, both as microencapsulated powder and aqueous extracts, following exposure to in vitro simulated digestion. Moreover, the impact of maltodextrin and glucose microencapsulation carriers on the extracts' phenolic content was assessed. Prior to encapsulation, the viscosity of the emulsions was shown at a shear stress of 50 s dilatant and a Newtonian behaviour above this value with a final viscosity between 1.024 and 1.049 mPa·s. The final microencapsulation yield for the samples ranged between 79 and 81%. Although the microencapsulated forms presented a targeted release at the intestinal level, the phenolic content decreased after gastrointestinal digestion. The bioaccessibility of the microencapsulated extracts showed higher values than their non-encapsulated counterparts, with the highest value of 45.43% in the VVIT sample, followed by VCS with 41.07%. However, the non-encapsulated VCS sample presented high bioaccessibility after in vitro digestion (38.65%). As concluded, further in vivo research should be conducted on the leaves of the species.

摘要

近年来,某些物种(越橘 - VMT、欧洲越橘 - VVIT和蓝莓 - VCS)因其潜在的健康益处而引发了特别的关注。最新研究表明,它们是营养保健品的重要替代来源,因为其叶子是浆果采摘的主要副产品。本研究旨在调查这些物种叶子中酚类化合物在体外模拟消化后的生物可及性,包括微胶囊粉末和水提取物形式。此外,还评估了麦芽糊精和葡萄糖微胶囊载体对提取物酚类含量的影响。在包封之前,乳液在50 s剪切应力下表现出胀流性,在此值以上呈现牛顿流体行为,最终粘度在1.024至1.049 mPa·s之间。样品的最终微胶囊化产率在79%至81%之间。尽管微胶囊形式在肠道水平呈现靶向释放,但胃肠道消化后酚类含量降低。微胶囊化提取物的生物可及性高于未包封的提取物,VVIT样品中的最高值为45.43%,其次是VCS为41.07%。然而,未包封的VCS样品在体外消化后具有较高的生物可及性(38.65%)。结论是,应对这些物种的叶子进行进一步的体内研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/9030406/c7e9c4e1070a/antioxidants-11-00674-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验